Trials that use: Exact / Clopper-Pearson binomial
New to this method? Read the tutorial →
1,265 results
- HW005Independent statistical analysis of Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609842).
- Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hypofractionated IMRT With Temozolomide for HGG: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated IMRT With Temozolomide for HGG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02082119).
- Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- I-SCREENIndependent statistical analysis of Increasing Screening for Cancer Using EHR-Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06177795).
- Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ICIP-SAIndependent statistical analysis of Invasive Candidiasis in Saudi ICUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01490684).
- iCLAS™ for Persistent Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of iCLAS™ for Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04061603).
- Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: Complete Statistical AnalysisIndependent statistical analysis of Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IDEAIndependent statistical analysis of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04425863).
- IKEEGIndependent statistical analysis of EEG Changes With Guided Online Meditation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03459690).
- IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: Complete Statistical AnalysisIndependent statistical analysis of IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00524342).
- IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT: Complete Statistical AnalysisIndependent statistical analysis of IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Image Guidance for Improved Vessel Cannulation in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Image Guidance for Improved Vessel Cannulation in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04031495).
- Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Immediate Loading and Fully Guided Surgery: Single Implants: Complete Statistical AnalysisIndependent statistical analysis of Immediate Loading and Fully Guided Surgery: Single Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04061694).
- IMMULAB – Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMPACTIndependent statistical analysis of Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle: Complete Statistical AnalysisIndependent statistical analysis of Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Implementation and Impact of an Online Tool Used in Primary Care to Improve Income Security: Complete Statistical AnalysisIndependent statistical analysis of Implementation and Impact of an Online Tool Used in Primary Care to Improve Income Security: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program: Complete Statistical AnalysisIndependent statistical analysis of Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Implementation of Pedometer for Monitoring Step Count Pre and Post Lumbar ESI for Radicular Pain: Complete Statistical AnalysisIndependent statistical analysis of Implementation of Pedometer for Monitoring Step Count Pre and Post Lumbar ESI for Radicular Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care: Complete Statistical AnalysisIndependent statistical analysis of Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Improve SCA Bridge Study: Complete Statistical AnalysisIndependent statistical analysis of Improve SCA Bridge Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03715790).
- Improving ADHD Behavioral Care: Complete Statistical AnalysisIndependent statistical analysis of Improving ADHD Behavioral Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03628781).
- Improving COVID-19 Vaccine Uptake in Nursing Homes: Complete Statistical AnalysisIndependent statistical analysis of Improving COVID-19 Vaccine Uptake in Nursing Homes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04732819).
- Improving Physical Activity With Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Improving Physical Activity With Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05370118).
- Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: Complete Statistical AnalysisIndependent statistical analysis of Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05734989).
- Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans: Complete Statistical AnalysisIndependent statistical analysis of Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00816036).
- IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients: Complete Statistical AnalysisIndependent statistical analysis of Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Increasing Optimal Use of HPV Vaccination in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Increasing Optimal Use of HPV Vaccination in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04180462).
- Independent Predictors of Mortality in Polytrauma Patients: Complete Statistical AnalysisIndependent statistical analysis of Independent Predictors of Mortality in Polytrauma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669577).
- Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer: Complete Statistical AnalysisIndependent statistical analysis of Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03416153).
- Individualized Stereotactic Body Radiotherapy of Liver Metastases: Complete Statistical AnalysisIndependent statistical analysis of Individualized Stereotactic Body Radiotherapy of Liver Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01239381).
- Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain: Complete Statistical AnalysisIndependent statistical analysis of Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain: primary endpoint results, effect estimate with confidence…
- INNOVATIONIndependent statistical analysis of A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- INROADSIndependent statistical analysis of A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…